ESMO World Congress on GI Cancer 2023

home / post-conference-perspectives / esmo-world-congress-on-gi-cancer-2023

John L. Marshall, M.D., discusses highlights of the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2023 and the latest advancements in colorectal cancer treatment.

EP. 1: Health-Related Quality of Life Outcomes in Metastatic Colorectal Cancer: Takeaways from the SUNLIGHT Study

August 7th 2023

John L. Marshall M.D., shares insights on health-related quality of life (HRQoL) findings from SUNLIGHT study presented at ESMO World Congress on Gastrointestinal Cancer (ESMO GI) 2023.

Watch

EP. 2: Maximizing Patient Quality of Life through Shared Decision Making in Metastatic Colorectal Cancer

August 14th 2023

Discussion on shared decision making with patients with later stage refractory metastatic colorectal cancer as well as maximizing a patient's quality of life.

Watch

EP. 3: Impact of Microsatellite Stability in Metastatic Colorectal Cancer

August 21st 2023

Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer.

Watch

$Botensilimab and Balstilimab in Refractory Microsatellite Stable (MSS) mCRC$

EP. 4: Botensilimab and Balstilimab in Refractory Microsatellite Stable (MSS) mCRC

August 28th 2023

An overview of data presented at ESMO GI 2023 on combined botensilimab and balstilimab therapy in heavily pretreated patients with microsatellite stable metastatic colorectal cancer.

Watch

EP. 5: Development Challenges in Microsatellite Stable mCRC

September 4th 2023

Dr Marshall discusses challenges associated with microsatellite stable metastatic colorectal cancer.

Watch

EP. 6: LEAP-017: Lenvatinib and Pembrolizumab in MSS mCRC

September 11th 2023

The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.

Watch

EP. 7: Innovations Needed in GI Cancer and Key Takeaways from ESMO 2023

September 18th 2023

John L. Marshall M.D., explains the importance of in-person conferences and the future of AI in the field.